Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey
暂无分享,去创建一个
Andreas Voss | Dan Ziegler | Wolfgang Rathmann | Christa Meisinger | Annette Peters | Siegfried Perz | Michael Roden | W. Rathmann | A. Peters | C. Meisinger | F. T. E. Group | M. Roden | A. Voss | S. Perz | D. Ziegler | A. Strom | Alexander Strom | for the KORA Study Group | A. Peters
[1] S. Tesfaye,et al. Autonomic dysfunction and circadian blood pressure variations in people with impaired glucose tolerance , 2013, Diabetic medicine : a journal of the British Diabetic Association.
[2] Zihui Tang,et al. A Simple Chinese Risk Score Model for Screening Cardiovascular Autonomic Neuropathy , 2014, PloS one.
[3] J. Kurths,et al. Nonlinear analysis of complex phenomena in cardiological data , 2000, Herzschrittmachertherapie und Elektrophysiologie.
[4] P. Wahl,et al. Prevalence of Complications Among Second-Generation Japanese-American Men With Diabetes, Impaired Glucose Tolerance, or Normal Glucose Tolerance , 1987, Diabetes.
[5] J. Tuomilehto,et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. , 2002, European heart journal.
[6] H. Calkins,et al. Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. , 1997, Circulation.
[7] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.
[8] J. Shaw,et al. Epidemiology of polyneuropathy in diabetes and prediabetes. , 2014, Handbook of clinical neurology.
[9] Myocardial sympathetic innervation in patients with impaired glucose tolerance: relationship to subclinical inflammation. , 2008, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[10] R. Kronmal,et al. The relationship of heart rate and heart rate variability to non‐diabetic fasting glucose levels and the metabolic syndrome: The Cardiovascular Health Study , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[11] A. Perciaccante,et al. Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus , 2006, BMC cardiovascular disorders.
[12] A Voss,et al. Short-term heart rate variability—age dependence in healthy subjects , 2012, Physiological measurement.
[13] Jeroen J. Bax,et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of theEuropeanSocietyofCardiology(ESC)anddevelopedincollaboration , 2014 .
[14] A Schirdewan,et al. Forecasting of Life Threatening Arrhythmias Using the Compression Entropy of Heart Rate , 2004, Methods of Information in Medicine.
[15] B. Hoogwerf,et al. Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. , 2002, Diabetes.
[16] A. Vinik,et al. Neuropathy in prediabetes: does the clock start ticking early? , 2011, Nature Reviews Endocrinology.
[17] O. Melander,et al. Soluble Urokinase Plasminogen Activator Receptor: A Risk Factor for Carotid Plaque, Stroke, and Coronary Artery Disease , 2014, Stroke.
[18] Matteo Anselmino,et al. Diabetes, prediabetes and cardiovascular risk , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[19] T. Tanridag,et al. Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance , 2008, Diabetes/metabolism research and reviews.
[20] Richard A. Johnson,et al. A new family of power transformations to improve normality or symmetry , 2000 .
[21] G. Breithardt,et al. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .
[22] W. Rathmann,et al. Prediction of Mortality Using Measures of Cardiac Autonomic Dysfunction in the Diabetic and Nondiabetic Population , 2008, Diabetes Care.
[23] A. Vinik,et al. Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.
[24] A. Antonelli,et al. Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[25] Jagmeet P. Singh,et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). , 2000, The American journal of cardiology.
[26] A. Malliani,et al. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .
[27] Antti M Kiviniemi,et al. Heart rate variability and the metabolic syndrome: a systematic review of the literature , 2014, Diabetes/metabolism research and reviews.
[28] W. Rathmann,et al. Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[29] L. Chambless,et al. Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. , 2005, Diabetes care.
[30] Pere Caminal,et al. Methods derived from nonlinear dynamics for analysing heart rate variability , 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[31] Chih-Hsing Wu,et al. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. , 2007, The Journal of clinical endocrinology and metabolism.
[32] H. Löwel,et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000 , 2003, Diabetologia.
[33] T. Chen,et al. Prevalence and Risk Factors of Somatic and Autonomic Neuropathy in Prediabetic and Diabetic Patients , 2009, Neuroepidemiology.
[34] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.
[35] P. Kumarathurai,et al. Soluble urokinase plasminogen activator receptor, C‐reactive protein and triglyceride are associated with heart rate variability in non‐diabetic Danes , 2013, European journal of clinical investigation.
[36] A. Voss,et al. Blood Pressure Variability as Sign of Autonomic Imbalance in Patients with Idiopathic Dilated Cardiomyopathy , 2012, Pacing and clinical electrophysiology : PACE.
[37] K. Khunti,et al. Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis , 2013, Diabetologia.
[38] R. Heethaar,et al. Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study , 2000, Diabetologia.
[39] J. Eriksson,et al. Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[40] B. Stricker,et al. Short-term QT variability markers for the prediction of ventricular arrhythmias and sudden cardiac death: a systematic review , 2014, Heart.
[41] G. Rossi,et al. Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003). , 2008, Diabetes Care.
[42] Mark E Molitch,et al. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. , 2006, Diabetes care.
[43] M. Haigney,et al. QT Variability Index. , 2013, Progress in cardiovascular diseases.
[44] J. Tuomilehto,et al. Cardiovascular Disease Mortality in Europeans in Relation to Fasting and 2-h Plasma Glucose Levels Within a Normoglycemic Range , 2010, Diabetes Care.
[45] S. Subramanian,et al. Association between Cardiac Autonomic Function, Oxidative Stress and Inflammatory Response in Impaired Fasting Glucose Subjects: Cross-Sectional Study , 2012, PloS one.
[46] Pere Caminal,et al. Short-term vs. long-term heart rate variability in ischemic cardiomyopathy risk stratification , 2013, Frontiers in Physiology.
[47] Andreas Voss,et al. Influence of age and gender on complexity measures for short term heart rate variability analysis in healthy subjects , 2013, 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).
[48] D. Williamson,et al. Modeling the impact of prevention policies on future diabetes prevalence in the United States: 2010–2030 , 2013, Population Health Metrics.
[49] R. Petrella,et al. Diabetes and Technology for Increased Activity Study: The Effects of Exercise and Technology on Heart Rate Variability and Metabolic Syndrome Risk Factors , 2013, Front. Endocrinol..